Uya Chuluunbaatar, Ph.D.
bio image

Partner, Avoro Ventures

Dr. Chuluunbaatar is a Partner at Avoro Ventures. Uya has over 15 years of healthcare experience across a range of functions including venture capital, public equity investing, technology transfer and academic research. Prior to joining Avoro Ventures, Uya was a Principal at Amzak Health where she led private and public biotech investments. Prior to Amzak, Uya was a sell side biotech equity research analyst at Goldman Sachs, covering large and mid-cap companies. Uya completed her Ph.D in Microbiology at New York University School of Medicine, conducting research in virus-host interactions. Her work was published in several scientific, peer-reviewed journals. She holds a B.S. in Biochemistry from Cornell University. Uya currently serves on the board of Hemab Therapeutics.